Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study - Nathan, SD; Behr, J; Collard, HR (Lancet Respir Med, 2019)
et al.